Author:
Smith Roy E.,Good Barbara C.
Reference131 articles.
1. Porter S. Human immune response to recombinant human proteins. J Pharm Sci 2001; 90: 1–11.
2. Schwartz RH, In: Paul WE, ed., Fundamental Immunology. Philadelphia: Lippincot-Raven. 1999: 701–740.
3. Braun A, Kwee L, Labow MA, et al. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice. Pharm Res 1997; 14: 1472–1478.
4. Meager A, Wadhwa M, Bird C, et al. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology 1999; 97: 536–532.
5. Wadhwa M, Skog A-LH, Bird C, et al. Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF. Clin Cancer Res 1999; 5: 1353–1361.